Silo Pharma Announces $2.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules July 19, 2024
SciSparc Signs Non-Binding Letter of Intent for Exclusive Global Out-Licensing of Pain Treatment for Approximately $6 million July 17, 2024
Algernon Pharmaceuticals Reports Results of Study Showing 93% Cough Suppression with Ifenprodil July 16, 2024